Yu Li

Summary

Affiliation: Boston University
Country: USA

Publications

  1. pmc Retinoic acid receptor β stimulates hepatic induction of fibroblast growth factor 21 to promote fatty acid oxidation and control whole-body energy homeostasis in mice
    Yu Li
    Department of Medicine, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    J Biol Chem 288:10490-504. 2013
  2. pmc Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21
    Yu Li
    Department of Medicine, Boston University School of Medicine, Boston, Massachusetts Electronic address
    Gastroenterology 146:539-49.e7. 2014
  3. pmc Activation of sterol regulatory element binding protein and NLRP3 inflammasome in atherosclerotic lesion development in diabetic pigs
    Yu Li
    Vascular Biology Section, Department of Medicine, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts, United States of America
    PLoS ONE 8:e67532. 2013
  4. doi request reprint The impact of splenectomy on human coronary artery atherosclerosis and vascular macrophage distribution
    Yu Li
    Harvard T H Chan School of Public Health, Boston, MA, 02115, USA Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA
    Cardiovasc Pathol 25:453-460. 2016
  5. pmc Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver
    Yu Li
    Department of Medicine, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts, 02118, USA
    FASEB J 25:1664-79. 2011

Detail Information

Publications5

  1. pmc Retinoic acid receptor β stimulates hepatic induction of fibroblast growth factor 21 to promote fatty acid oxidation and control whole-body energy homeostasis in mice
    Yu Li
    Department of Medicine, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    J Biol Chem 288:10490-504. 2013
    ..The hepatic RAR-FGF21 pathway may represent a potential drug target for treating metabolic disorders...
  2. pmc Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21
    Yu Li
    Department of Medicine, Boston University School of Medicine, Boston, Massachusetts Electronic address
    Gastroenterology 146:539-49.e7. 2014
    ..Hepatic overexpression of SIRT1 reduces steatosis and glucose intolerance in obese mice. We investigated mechanisms by which SIRT1 controls hepatic steatosis in mice...
  3. pmc Activation of sterol regulatory element binding protein and NLRP3 inflammasome in atherosclerotic lesion development in diabetic pigs
    Yu Li
    Vascular Biology Section, Department of Medicine, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts, United States of America
    PLoS ONE 8:e67532. 2013
    ..However, whether SREBP is involved in vascular lipid accumulation and inflammation in atherosclerosis remains largely unknown...
  4. doi request reprint The impact of splenectomy on human coronary artery atherosclerosis and vascular macrophage distribution
    Yu Li
    Harvard T H Chan School of Public Health, Boston, MA, 02115, USA Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA
    Cardiovasc Pathol 25:453-460. 2016
    ..In this study, the direct impact of splenectomy on human coronary artery atherosclerotic plaque severity and macrophage content was investigated...
  5. pmc Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver
    Yu Li
    Department of Medicine, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts, 02118, USA
    FASEB J 25:1664-79. 2011
    ....